All posts by imreal

The National Children’s Cancer Society Offers Free Publications to Guide Kids and Families on Their Cancer Journey


The National Children’s Cancer Society (NCCS) offers several free publications that provide helpful information to kids battling cancer and their families. These resources cover a variety of topics and are useful before, during and after treatment.

The NCCS currently offers six publications including a guide for parents, an interactive activity book for kids in treatment, advice for friends of children with cancer and tips about going to college for cancer survivors. These resources come in a range of formats for different age groups—from a coloring book for young children to digital materials for teens. Each publication provides a valuable way for children and those close to them to anticipate and process their experiences.

“The publications we requested from the NCCS provided us with quite a bit of information on how to deal with not only current issues, but situations that are expected in the future. It means a lot to us to have these free resources available,” said a parent served by the NCCS.

The NCCS is committed to helping families get where they need to be physically, financially and emotionally during the treatment and ongoing challenges of childhood cancer.

“These resources provide families with straightforward and comforting tools to be able to navigate the long and hard journey of childhood cancer,” said Aleeza Granote, LCSW, of Cardinal Glennon Children’s Hospital. “Every one of our families receives ‘The Other Side of the Mountain: A Parent’s Guide to Surviving Childhood Cancer’ at diagnosis. Our most-received responses on this publication and others are how easy they are to read and how they make the families feel they are not alone.”

Find these free resources in a PDF format ready to download, or order print copies, on the NCCS website (http://www.thenccs.org/publications). Hospitals or medical professionals wishing to order large quantities for patients can contact the NCCS for assistance at 314-241-1600 ext. 214.

The National Children’s Cancer Society (NCCS), headquartered in St. Louis, Mo., is a not-for-profit organization providing support to families making their way through the daunting world of childhood cancer and survivorship. With over 30 years of experience serving more than 44,000 children, the NCCS is able to take a “no matter what” approach to help families stay strong, stay positive and stay together. The NCCS has been recognized as a Better Business Bureau Accredited Charity and earned a GuideStar Platinum Seal of Transparency. For more information, call 314-241-1600, visit http://www.theNCCS.org or follow on Facebook (http://www.facebook.com/thenccs), Twitter (http://www.twitter.com/The_NCCS) and Instagram (http://www.instagram.com/thenccs/).

Share article on social media or email:



Convoy of Hope Launches National COVID-19 Response


News Image

Convoy of Hope truck

“This is a united act of compassion,” said Hal Donaldson, president of Convoy of Hope. “Churches, businesses, civic organizations, and local governments are coming together to help children and families get through this difficult period.”

In response to the COVID-19 pandemic, Convoy of Hope, a global relief organization, is aiming to supply partners with 10 million meals to distribute across the United States. Already underway, the meals are being distributed through churches and civic organizations in communities hit hard by the coronavirus.

“This is a united act of compassion,” said Hal Donaldson, president of Convoy of Hope. “Churches, businesses, civic organizations, and local governments are coming together to help children and families get through this difficult period. Many families have lost employment and, with school closures, children have lost access to school lunch programs,” Donaldson said. “The need is great — we have received hundreds of requests for food from 35 states.”

This week, Convoy of Hope’s fleet of tractor-trailers has delivered more than 60 loads of goods around the country. Much of the food has been donated by major corporations; because of current demands on suppliers, some of the food is being purchased at below wholesale prices. Additional resources will be needed as the new virus continues to spread and needs increase exponentially.

“With the public’s help, we will deliver 10 million meals—and hopefully even more—to those who need them most,” said Donaldson. “Like our response to any major disaster or crisis, we intend to do as much as we can for as long as we can.”

Convoy of Hope is a faith-based, nonprofit organization with a driving passion to feed the world through children’s feeding initiatives, community outreaches, and disaster response. Visit convoyofhope.org to donate to their response.

About Convoy of Hope

Convoy of Hope is a faith-­based organization with a driving passion to feed the world. With a long history as an early responder in times of natural disasters, Convoy of Hope has been a Four Star Charity as recognized by Charity Navigator for 16 consecutive years. Convoy of Hope has served more than 130 million people since it was founded in 1994. For more information, please visit convoyofhope.org.

Share article on social media or email:

SkillsUSA and Industry Leaders Come Together to Help CTE Students Continue Learning During COVID-19 Crisis


News Image

This is our effort to offer support to our students and teachers who need guidance and resources — and they need it right now

To support continued learning for career and technical education (CTE) students during the COVID-19 crisis, SkillsUSA has joined with Lincoln Electric, Tooling U-SME, NC3 and camInstructor to form the CTE Coalition. The coalition has quickly mobilized to create the Keep CTE Moving website, a central portal where instructors and students can access hundreds of online classes, videos, and instructional materials in areas such as machining, welding, mechatronics, industry 4.0, and programming. All online materials — many available at no charge for the next 30 days — are produced by the coalition partners. The goal is to help CTE faculty and students continue their teaching and learning in a new virtual environment as quickly as possible.

“The coalition hopes that by offering these centralized online resources, we can quickly help thousands of students continue their studies in these unprecedented times when many schools are temporarily closed,” said SkillsUSA executive director Chelle Travis. “This is our effort to offer support to our students and teachers who need guidance and resources — and they need it right now.”

“A lot of CTE courses in areas like welding, CNC, automotive, manufacturing and construction are very hands-on,” said Jason Scales, business manager, education, Lincoln Electric. “Many instructors simply don’t have online training content. This non-competitive group of industry-leading companies each maintain a robust set of e-learning modules and other resources. Together, we agreed to share our resources in an unprecedented manner. With this opportunity, tens of thousands of CTE students can keep learning, even while they may not be allowed to gather in a physical classroom or lab.

Understanding the urgency for education to respond to the crisis, coalition partners are also providing recorded sessions with CTE instructors highlighting best practices in how to effectively utilize e-learning and online resources to educate students and quickly transition to a virtual learning environment. The manufacturing industry has already faced a skilled labor shortage, and the continuing COVID-19 crisis has presented an additional challenge for educational institutions as schools across the nation are closed and face-to-face learning is disrupted.

Given the changing nature of the COVID-19 situation, CTE instructors are urged to visit the Keep CTE Moving website at http://www.ctecoalition.com regularly for new learning resources and guidance that will evolve over time. The coalition will continue to monitor the situation and work together to respond to the needs of CTE educators and their students.

About SkillsUSA

SkillsUSA is a nonprofit partnership of education and industry founded in 1965 to strengthen our nation’s skilled workforce. Driven by employer demand, SkillsUSA helps students develop necessary personal and workplace skills along with technical skills grounded in academics. This SkillsUSA Framework empowers every student to succeed at work and in life, while helping to close the skills gap in which millions of positions go unfilled. Through SkillsUSA’s championships program and curricula, employers have long ensured schools are teaching relevant technical skills, and with SkillsUSA’s new credentialing process, they can now assess how ready potential employees are for the job. SkillsUSA has more than 366,000 annual paid members nationwide in high schools, colleges and middle schools, covering over 130 trade, technical and skilled service occupations, and is recognized by the U.S. departments of Education and Labor as integral to career and technical education. With the addition of our alumni, membership last year was 427,432. We have served nearly 14 million members since 1965. For more information: https://www.skillsusa.org/

For more information on the Keep CTE Moving site and CTE Coalition efforts, visit https://ctecoalition.com/

Visit CTE Coalition members’ websites, including Lincoln Electric, https://www.lincolnelectric.com/en-us/; Tooling U-SME, https://www.toolingu.com/; NC3, https://www.nc3.net/; camInstructor, https://caminstructor.com/; and SkillsUSA, https://www.skillsusa.org/

Share article on social media or email:

Microderm GLO Ranks No. 5 on the 2020 Inc. 5000 Series: Midwest List


Microderm GLO Diamond Microdermabrasion System

Microderm GLO Diamond Microdermabrasion System

Microderm GLO is passionate on bringing traditionally expensive, in-office, professional dermatologist care into everyone’s home.

Inc. magazine today revealed that Microderm GLO is No. 5 on its inaugural Inc. 5000 Series: Midwest list, the most prestigious ranking of the fastest-growing private companies in Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin. Born of the annual Inc. 5000 franchise, this regional list represents a unique look at the most successful companies within the Midwest economy’s most dynamic segment—its independent small businesses.

“Not only is it very exciting but it is also a tremendous honor to be ranked in the top 2% of the fastest growing companies in the Midwest by Inc.,” says Microderm GLO founder and CEO Sid Param, “It would have been impossible to reach this point without the dedication of many important people – the relentlessness of our team, the trust and voice of our raving fans, and the inspiration and mentorship from organizations that have recognized and supported us over the years.”

The companies on this list show stunning rates of growth across all industries in the 12 Midwest states. Between 2016 and 2018, these 250 private companies had an average growth rate of 360 percent and, in 2018 alone, they employed more than 27,000 people and added $13 billion to the Midwest’s economy. Companies based in the Chicago, Detroit, and Cincinnati areas brought in the highest revenue overall.

Complete results of the Inc. 5000 Series: Midwest, including company profiles and an interactive database that can be sorted by industry, metro area, and other criteria, can be found at inc.com/inc5000-series-midwest-2020 starting March 25, 2020.

“The companies on this list demonstrate just how much the small-business sector impacts the economies of each Midwest state,” says Inc. editor in chief Scott Omelianuk. “Across every single industry, these businesses have posted revenue and growth rates that are beyond impressive, further proving the tenacity of their founders and CEOs.”

About Microderm GLO

Microderm GLO develops, manufactures, and markets professional-grade, dermatological and healthcare products. On a mission to help people look and feel their best every day, Microderm GLO is passionate on bringing traditionally expensive, in-office, professional dermatologist care into everyone’s home.

While customers choose Microderm GLO for their award-winning, breakthrough skincare products, they stay for the company’s uncompromising commitment to world-class customer happiness and industry-leading lifetime warranty on every product.

For more information about Microderm GLO, visit us at MicrodermGLO.com or connect with us on Facebook and Instagram.

Contact:

Microderm GLO Skincare

Media & PR Department

media@microdermglo.com

888-745-7333

More About Inc. and the Inc. 5000 Regional Series

Methodology

The 2020 Inc. 5000 Regional Series is ranked according to percentage revenue growth when comparing 2016 and 2018. To qualify, companies must have been founded and generating revenue by March 31, 2016. They had to be U.S.-based, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2018. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2016 is $100,000; the minimum for 2018 is $1 million. As always, Inc. reserves the right to decline applicants for subjective reasons.

About Inc. Media

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit http://www.inc.com.

Share article on social media or email:



Fenway Health policy brief outlines impact of COVID-19 on people living with HIV and LGBTQIA+ people


An image of the cover of the brief on COVID-19 and People Living with HIV and LGBTQIA+ People

Because of higher rates of chronic disease and risk factors like smoking and vaping, LGBTQIA+ people and people living with HIV should strictly adhere to social distancing guidelines and take care of their health as best they can right now.”

Today, The Fenway Institute of Fenway Health released a policy brief outlining the ways in which people living with HIV and LGBTQIA+ people are likely to be affected by COVID-19 and the factors that may put them at elevated risk for infection.

“Everyone is at risk of infection in this pandemic. But history shows that people who are marginalized and consequently experience disparities in health will suffer disproportionately greater harms than the general population,” said Sean Cahill, Director of Health Policy Research at The Fenway Institute. “Because of higher rates of chronic disease and risk factors like smoking and vaping, LGBTQIA+ people and people living with HIV should strictly adhere to social distancing guidelines and take care of their health as best they can right now.”

People with chronic health conditions, including HIV/AIDS, may be at elevated risk of serious complications from COVID-19. Of most concern are people living with HIV who are not treatment adherent and virally suppressed. People living with HIV should make every effort to adhere to their treatment regimen by taking their HIV medication daily and engaging in other activities to remain healthy such as eating well, exercising, and avoiding tobacco and other substances.

More specifically, people living with HIV should:


  • Ensure that they have at least a 30-day supply of medications on hand; in Massachusetts, under Governor Baker’s emergency declaration, people can get a 60- to 90-day day supply of medication;
  • Make sure that they are up to date with flu and pneumonia vaccines;
  • Establish a plan for clinical care if isolated or quarantined, for example using telemedicine via Skype or FaceTime; and
  • Maintain a social network, but remotely—as social contact can help with mental health and also fights boredom.

Due to experiences of discrimination in health care settings as well as the impact of stigma and minority stress on health, LGBTQIA+ people are more likely to have some of the underlying health conditions that could increase their vulnerability if they are exposed to the novel coronavirus.

  • Gay and bisexual men, as well as transgender women, have disproportionately higher rates of HIV
  • Lesbian women are more likely to have poor or fair health, multiple chronic conditions, heavy driving and heavy smoking compared with straight, cisgender women
  • Bisexual women are more likely to have multiple chronic conditions, severe psychological distress, and engage in heavy drinking and moderate smoking
  • Lesbians, gay men, and bisexuals of all ages are more likely to be living with disabilities than the general population
  • LGBTQ youth have higher rates of sedentarism, pre-diabetes, and diabetes
  • LGBT people are more likely to smoke and vape, and to use substances.
  • LGBT older adults experience higher rates of social isolation than straight and cisgender age peers

(Citations for the above can be found here.)

“A real concern for LGBTQIA+ people during this pandemic is that we know that they avoid seeking needed health care due to previous experiences of discrimination in health care settings or the fear of experiencing discrimination,” Cahill added. “We’ve also seen new policies enacted at the federal level and in some states that make it easier for health care providers to refuse treatment based on religious or moral beliefs. Discrimination in health care is never acceptable. During an unprecedented global health emergency, this is especially true.”

The policy brief, “Coronavirus, COVID-19, and Considerations for People Living with HIV and LGBTQIA+ People,” can be downloaded as a PDF here.

Since 1971, Fenway Health has been working to make life healthier for the people in our neighborhoods, the LGBTQIA+ community, people living with HIV/AIDS and the broader population. The Fenway Institute at Fenway Health is an interdisciplinary center for research, training, education and policy development focusing on national and international health issues.

Share article on social media or email:

Palo Alto University BRAIN Lab Encourages Baseline Concussion Testing for Athletic Teens


“We could test entire teams at a school and coaches through our website and social media”

Every year, an estimated 3.8 million athletes suffer a concussion, and 70 percent of related ER visits are by children and teenagers. Rayna Hirst, Ph.D., associate professor of neuropsychology at Palo Alto University (PAU), isn’t surprised by these statistics. In her Behavioral Research and Assessment in Neuropsychology (BRAIN) Lab, where she is studying the effects of sports-related concussions, she says more than a third of the test subjects have had a mild traumatic brain injury. What she found astonishing is that parents of half of those kids did not seek medical attention, just the sort of behavior that Brain Injury Awareness Month, observed this month, aims to change. Hirst is passionate about educating the public about brain injuries and is available for interviews.

While Hirst’s study is in its early stages, with several papers published so far, Hirst and her team have uncovered some unexpected findings. Football gets most of the attention, but many youth athletes sustained concussions while involved in high-impact activities outside of organized sports, such as sailing, dirt biking and recreational basketball. Furthermore, when it comes to organized sports, athletes in positions where they are repeatedly tackled are at higher risk, while body mass index, age and the number of years of exposure were unrelated.

To recruit subjects for the study (which is temporarily on hold due to COVID-19 restrictions), Hirst offers free neuropsychological evaluation for athletes ages 8-16. Her team reviews each child’s medical history, interview the participant and a family member or caregiver, and administer a battery of tests that assess the youth’s memory, concentration, problem-solving skills and other cognitive functions. Parents get a detailed report of their child’s cognitive strengths and weaknesses. Athletes can be retested after a concussion, with the results compared to the baseline to help determine treatment and decisions about when a student can resume regular activity and return to the sport. Hirst also recommends retesting every year or two, also free “because kids develop cognitively at different rates.”

She says a healthy child may have abnormal scores on cognitive testing even on the baseline assessment, so she cautions parents not to read too much into one or two low scores. It’s also important to know those low baseline scores so they can be interpreted correctly in the event of an injury.

Hirst emphasizes the community service aspect of the concussion study. At the high school level, she says, many sports programs do basic baseline screening of athletes at the beginning of each season. However, middle schools and schools in lower socioeconomic regions don’t have the funds. That is where Hirst and her team can step in. By offering free testing, they are giving parents and school or league administrators access to a service they wouldn’t otherwise have. The study also offers information and resources for parents and coaches through their website and social media.

So far, the study’s database comprises about 130 youth, with longitudinal data on 30 of them, and Hirst would like to grow that number. Assessments are typically done in the lab, but “we can be mobile,” Hirst says. “We could test entire teams at a school and coaches through our website and social media”.

About Rayna Hirst, Ph.D.

Rayna Hirst is an associate professor and director of the Neuropsychology Program at Palo Alto University, providing didactic and supervisory education to doctoral students who are training in neuropsychology. Her research focuses on the validity and interpretation of neuropsychological assessment in a variety of clinical disorders. She also serves as the Research Director at San Francisco Neuropsychology PC, leading their clinical research program. She is a member of the National Academy of Neuropsychology Conflict of Interest Committee, the International Neuropsychological Society, and is Member-at-large and former Treasurer of the Northern California Neuropsychology Forum.

She completed her doctorate in Clinical Psychology, with a specialization in Neuropsychology, at the University at Albany, State University of New York. She completed her internship at the VA Ann Arbor/University of Michigan Healthcare System. Her postdoctoral fellowship was at the Dartmouth-Hitchcock Medical Center, in the Geisel School of Medicine. Her broad and diverse training has prepared her for the assessment of a variety of neurological and psychological disorders. In her clinical practice, she sees adults aged 18 and over (including older adults), for all types of neuropsychological evaluations, including ADHD, learning disorder, psychiatric disorders (e.g., depression, anxiety), medical diagnoses (e.g., multiple sclerosis, Parkinson’s disease, traumatic brain injury, neuro-oncology), and dementia.

Share article on social media or email:

Measuring Cytopathic Effects of Viral Infections by Applied BioPhysics Inc.


Measuring Cytopathic Effects of Viral Infections by Applied BioPhysics Inc.

Cytopathic effects of viral infections upon cultured cells are difficult to quantify due to the subjective nature of monitoring cell morphology. Applied Biophysics provides instruments and specialized 96 well microplates to detect virus-induced morphological changes quantitatively and in real-time using an impedance-based electrical measurement.

Cells are seeded and grown to confluence upon gold electrodes located on the base of each well of the microplate. The formation of a confluent monolayer is verified using impedance measurements, and the cultures are then infected.

Following the latent period associated with the infection, one begins to see changes in the impedance associated with viral-induced cytopathic activities. Recording the impedance data over a range of AC frequencies allows one to discern different morphological alterations including cell rounding, loss of barrier function, the formation of syncytia, and cell detachment from the substrate. Based on these responses, researchers can begin to explore the effect of different experimental conditions, such as the addition of potential therapeutic compounds.

The Electric Cell-substrate Impedance Sensing (ECIS) measurement is highly sensitive, completely label-free, and non-invasive. All instruments come in turn-key packages ready to be used with your cell incubator and include all electronics, a laptop computer loaded with user-friendly ECIS software, and a supply of 96 well electrode arrays.

For more information and other applications of the ECIS technology please visit http://www.biophysics.com

For further information contact:            

Wendy Ladouceur                    

Applied BioPhysics                 

185 Jordan Road                    

Troy, NY 12180                     

Ph: 1-866-301-ECIS (3247)             

Fax 518-880-6860     

For technical questions:

Dr. Charles Keese

Applied BioPhysics

185 Jordan Road

Troy, NY 12180

Ph: 1-866-301-ECIS (3247)

Fax 518-880-6860

Share article on social media or email:

Meridian Clinical Research Continues to Support Trials at Sites Nationwide, Will Remain Operational Amid COVID-19 Pandemic


Meridian Clinical Research Logo

Meridian Clinical Research Logo

“We’re fully prepared to address any COVID-19 opportunity and support novel research and development programs. Our clients can expect Meridian to be fully staffed and operational throughout this pandemic.”

Meridian Clinical Research, a leading investigative research network, will remain open to support the research of investigational tests, vaccines, and medications intended for commercial release.

Meridian sites are working with Sponsors and contract research organizations (CROs) to ensure patient safety while continuing to enroll patients during the COVID-19 pandemic. The company has enrolled more than 25,000 subjects into vaccine and infectious disease clinical trials in the past 20 years. Nicole Osborn, CEO, says Meridian has always focused on protecting healthy participants and patients with acute conditions.

“We’re fully prepared to address any COVID-19 opportunity and support novel research and development programs,” said Osborn. “Our clients can expect Meridian to be fully staffed and operational throughout this pandemic. Our patients can be confident that every Meridian site is meeting and exceeding safety standards, and that we’re operating in line with state-specific regulations.”

To maintain proper social distancing, Meridian is supporting over-the-phone visits, telemedicine visits, and in-office visits with minimal exposure to others and intensified cleaning processes. In early March, Meridian began restricting work-related travel and in-person meeting attendance.

As a leading investigative site network for vaccine trials, Meridian has conducted first-in-human studies for emerging diseases. In 2015, the company supported a Phase I study for the Ebola vaccine when the outbreak occurred, and conducted research for Zika virus and anthrax vaccines in the past year.

Headquartered at its dedicated research center in Omaha, Nebraska, the company operates additional sites in Nebraska (Norfolk), Georgia (Savannah), Louisiana (Baton Rouge), Maryland (Rockville), New York (Binghamton, Endwell, Johnson City, Vestal), South Dakota (Dakota Dunes), and Virginia (Norfolk).

Sponsors and CROs interested in leveraging Meridian’s network for infectious disease trials should contact Andrew Kimball, vice president, business development, at akimball@mcrmed.com.

“We’re here to educate patients and people interested in the research process,” said Osborn. “The spread of COVID-19 gives us a chance to engage and inform more people about the importance of clinical research to address viruses like SARS-CoV-2.”

Patients who are currently enrolled in a Meridian trial are encouraged to call the site they’re visiting or the Meridian call center: (402) 934-7563 (LA, NE, SD) • (912) 623-2240 (GA, MD, NY, VA).

Visit mcrmed.com/vaccine to learn more about Meridian’s infectious disease capabilities. To view current studies and sign up to learn about new opportunities at Meridian’s locations across the U.S., visit mcrmed.com.

ABOUT MERIDIAN CLINICAL RESEARCH

Meridian Clinical Research partners with pharmaceutical and biotechnology companies to research new pharmaceutical drugs, medical devices, and diagnostics that could improve human health and wellbeing. Founded in 1999, Meridian is headquartered at a dedicated research center in Omaha, NE, and conducts Phase I-IV studies at investigative sites across North America. Meridian supports research across numerous therapeutic areas and specializes in high-volume vaccine trials. For more information, visit http://www.mcrmed.com.

Share article on social media or email:

Northern Virginia Community College’s Education Foundation Launches COVID-19 Emergency Student Relief Fund


NOVA remains open and committed to supporting students through remote learning and services

NOVA remains open and committed to supporting students through remote learning and services

Northern Virginia Community College’s Education Foundation Launches COVID-19 Emergency Student Relief Fund

Northern Virginia Community College (NOVA) Educational Foundation has launched a new emergency student aid fund to assist students struggling with the personal and economic fall-out from the COVID-19 pandemic. More than 60% of NOVA’s 85,000 students work full- or part-time jobs. For many, what little income they have is diminishing rapidly. Financially vulnerable students face furloughs and layoffs as a result of the pandemic, and as child-care options and schools close, student-parents are facing extreme challenges in keeping any employment.

The NOVA COVID-19 Emergency Student Aid Fund will help with the rapid delivery of emergency aid to students who need it most. NOVA’s aim is to meet students’ basic needs to help them stay in school and complete the semester. The goal is to raise $750,000 to provide at least 1,500 grants of $500 each.

The NOVA Foundation has committed $250,000 to kick-off the effort to encourage individual and corporate donors to join the Foundation in helping our future workforce stay strong.

“Ensuring every NOVA student succeeds is our highest priority always,” said Dr. Anne Kress, NOVA’s President. “But especially now, as our students face unprecedented challenges, we have an obligation to ensure they have our support. Our students will help our community rebuild and prosper but they can only do this if we provide the assistance they need. I encourage everyone to consider donating to the Emergency Student Aid Fund.”

Background

With an enrollment of more than 85,000 credit and non-credit students, NOVA is the 14th largest institution of higher learning in the United States. It offers 73 associate degree programs that lead to employment or university transfer opportunities and 61 certificate programs that teach specific skill sets such as healthcare and IT that are in demand across our region. NOVA graduates more than 6,000 students annually, making the College a leading source of talented hires for the region.

However, statistics only tell part of the story. NOVA students attend classes and succeed, often against great odds. More than 20% of NOVA students are the first in their families to attend college, and 76% of first-generation students belong to a racial or ethnic minority. NOVA students hail from more than 160 countries and speak nearly 120 different languages.

In January 2020, The Hope Center for College, Community, and Justice at Temple University (Philadelphia, Penn.) conducted a survey of NOVA students after the college held a ‘Student Needs Symposium’. The survey assessed the basic needs (defined as food or housing insecurity/homelessness) of NOVA students. More than 1,400 students participated and the assessment has become a telling benchmark of the challenges faced by students at two-year colleges across the nation.

The survey results confirmed what many faculty and staff long suspected about our student body – basic needs insecurity is a very real challenge to many students. The survey revealed:


  • 32% of respondents experienced food insecurity in the prior 30 days
  • 39% of respondents experienced housing insecurity in the previous year
  • 15% of respondents experienced homelessness in the previous year

49% of students at Northern Virginia Community College experienced at least one of these forms of basic needs insecurity in the past year

Challenge

This information has caused the college to mobilize quickly in the changing public health crisis caused by the COVID-19 pandemic. Northern Virginia Community College is dedicated to doing everything in its power to keep students in school to complete the current semester and continue progress toward their degrees.

Please consider making a tax-deductible donation to assist NOVA students during this challenging time. You may donate:

Online: https://nova.cbo.io

By Email: foundation@nvcc.edu

By Phone: 703-323-3023

###

For more information about NOVA and its programs or services, call 703-323-3000 or visit the College’s Web site, http://www.nvcc.edu.

Share article on social media or email:

The Sullivan Group & CareLoop Partner to Improve Patient Safety in Post-Discharge Care


We are now able to automate communication with every patient to perform timely and meaningful post-discharge check-ins, reducing the likelihood of adverse events and improving patient safety.

The Sullivan Group Innovation Lab and CareLoop, Inc., announced a new software development that improves patient safety during post-discharge care. SafeDischarge™, co-developed by CareLoop and The Sullivan Group, provides hospitals, health systems and physicians groups with a software solution to avoid adverse events by proactively communicating with patients and flagging those patients that are at increased risk of an adverse outcome.

Over the last decade, various alternative payment models have been proposed to help the U.S. healthcare system move toward value-based care and become more cost effective. In October 2019, US Department of Health and Human Services (HHS) Secretary Alex Azar endorsed an alternative payment model proposed by ACEP called Acute Unscheduled Care Model (AUCM). For organizations considering the adoption of these new models or having issues with adverse events related to discharge, this new platform helps mitigate risk by automating a series of patient safety protocols during the first 72 hours of post-discharge care.

“Most emergency physicians and nurses have probably practiced a call-back program by selecting a few concerning patients to check in,” stated Dan Sullivan, MD, JD, FACEP, President and CEO of The Sullivan Group. “Working with CareLoop, we are now able to automate communication with every patient to perform timely and meaningful post-discharge check-ins, reducing the likelihood of adverse events and improving patient safety.”

SafeDischarge™ draws from over 40 different algorithms developed from The Sullivan Group’s research into adverse events and litigation. Leveraging CareLoop’s mobile platform, patients are prompted to answer a series of questions related to their presenting complaint, condition or procedure. In the event patients are experiencing any of the symptoms in question, the care team is immediately notified and the patient is advised to seek the appropriate care.

While patient safety is paramount during a patient’s time in the acute care environment, it has been very difficult for the care team to stay informed on the patient’s condition after they leave. One well-recognized study by Dr. Alan Forster et al. found that over 19% of patients discharged from a teaching hospital sustained an adverse event within two weeks of leaving the hospital. Of those patients with adverse events, approximately one-third were deemed preventable, and another one-third were found to be more severe than necessary.

“As patient volumes shift toward virtual care over admission, the importance of safely discharging patients and staying connected with those patients post-charge is vitally important,” stated Dr. Foster Goss, an emergency physician, biomedical informaticist, and co-founder of CareLoop. “Safe Discharge™ will drive improved patient outcomes through enhanced communication, care coordination and an exceptional experience.”

About The Sullivan Group Innovation Lab

The Sullivan Group (TSG) has worked with over 1,000 acute care facilities, has been used by 95,000 clinicians, and has an impact on over 20 million patient visits annually. Its RSQ® Solutions platform has been used by some of the nation’s largest hospital systems to successfully reduce adverse outcomes. The TSG Innovation Lab partners with healthcare technology companies to co-develop new software products that lead to making a greater impact on patient safety, patient outcomes and the patient experience.

About CareLoop

CareLoop® is a healthcare communication experience company. CareLoop is reinventing the patient experience by extending the conversation beyond the legacy provider/patient engagement-only channel, empowering patients to loop in their healthcare providers, caregivers and family. This makes CareLoop a first-in-category player in the emerging conversational, omni-channel, always-on, always-connected solution space. CareLoop is building the advanced enterprise solution that enables providers to scale communication with consumer-based networks, stay in the loop throughout the individual’s journey in and out of the healthcare system, and therefore drive better health outcomes and care coordination. As a SaaS (Software as a Service) platform, CareLoop scales quickly within identified markets. That scalability is leveraged through a partnership with Redox, an EHR (electronic health record) integration company that has performed thousands of integrations among the largest EHRs (e.g., Epic Systems, Cerner Corp, Athena).

To learn more about how we are transforming healthcare, visit http://www.careloop.co.

Share article on social media or email: